Pictet Asset Management (Switzerland)’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $78.3M | Buy |
2,032,730
+28,433
| +1% | +$1.09M | 0.09% | 225 |
|
|
2023
Q1 | $71.7M | Sell |
2,004,297
-115,322
| -5% | -$4.13M | 0.09% | 237 |
|
|
2022
Q4 | $83.6M | Sell |
2,119,619
-167,746
| -7% | -$6.61M | 0.12% | 208 |
|
|
2022
Q3 | $82.6M | Buy |
2,287,365
+467,889
| +26% | +$16.9M | 0.12% | 204 |
|
|
2022
Q2 | $55.3M | Buy |
1,819,476
+494,150
| +37% | +$15M | 0.08% | 267 |
|
|
2022
Q1 | $40.5M | Buy |
+1,325,326
| New | +$40.5M | 0.05% | 353 |
|